AFP and hepatocellular carcinoma: First, the level of PEG-IgG, similar to what is observed with AFP and another potential biomarker, fucosylated kininogen, was reduced in patients who received a liver transplant, as compared to those with HCC (Supplementary Figure S5A–C).